The COVID19 pandemic has generally seen children co-operating with following necessary precautions. However, rampant misinformation circulating online has also had its toll on impressionable minds in the form of harmful anti-mask & anti-immunization (without medical reasons) attitudes. Moreover, stringent posturing, a chastising rhetoric and occasional confused messaging by some frustrated authorities w.r.t. COVID19 policies are only proving counter-productive.
When vaccines fall short in offering relevant immune protection in the Immunocompromised, what really works? When such suboptimal immune protection wanes a lot faster in comparison to that immunocompetent individuals, is there a better option?
“Ready-made”, sustainable Immune Protection perhaps?
Well that’s exactly what Evusheld ® – drugmaker AstraZeneca’s “New Kid on the Block” in the long-acting monoclonal antibody drug combo can potentially offer.